Molly Freeman, CNP, discusses the aftercare that goes into treating patients with lung cancer who have undergone stereotactic body radiation therapy (SBRT).
Molly Freeman, CNP, from Cleveland Clinic Cancer Center, discusses the aftercare that goes into treating patients with lung cancer who have undergone stereotactic body radiation therapy (SBRT).
SBRT is a treatment option for patients with lung cancer. It is a very well-tolerated therapy with minor adverse events -- such as fatigue, chest wall aching and the low possibility of radiation pneumonitis.
Pembrolizumab Plus Chemotherapy Continues to Display Survival Advantage Over Chemotherapy in NSCLC
March 24th 2023Patients with metastatic squamous non–small cell lung cancer experienced a clinically meaningful survival benefit when treated with pembrolizumab in combination with chemotherapy.
Are Hearing Tests Necessary For Adult Cancer Survivors?
September 15th 2022In this episode of “The Vitals,” Christine Miaskowski, PhD, RN, discusses research showcasing that adult patients receiving either a platinum-based chemotherapy, taxane alone, or a combined regimen of platinum- and taxane-based treatment may be at risk of hearing loss.
Lenvatinib Plus Pembrolizumab Elicits Durable Responses in Patients With Endometrial Cancer
Carolina Frailty Index Score May Be Applicable in Assessment of Patients with Ovarian Cancer
GCLQ and LELSQ Show Concordance in Assessment of Lymphedema in Patients With Endometrial Cancer
Pollack Discusses Ongoing Research for Patients With Refractory mCRC and Other Hard-to-Treat GI Malignancies
2 Clarke Drive
Cranbury, NJ 08512